about
Cabaletta Bio Inc is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies and exploring their potential to provide a deep and durable, perhaps curative, treatment for patients with B cell-medi...
Read More
3.18
-0.25
(-7.29%)
1.6M
XNAS Volume
XNAS 05 Mar, 2026 4:30 PM (EST)
Not Eligible
Expensive Valuation
Technically Bullish
Cabaletta Bio Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..